Wyden Eyes Bipartisan Bill To Address Wholesalers,’ GPOs’ Role In Drug Shortages

By Maaisha Osman / December 6, 2023 at 9:00 AM
Updated Story Senate Finance Committee Chair Ron Wyden (D-OR) says he will work on bipartisan legislation to address the issue of three wholesalers controlling 90% of the pharmaceutical market, saying highly consolidated middlemen like wholesalers and group purchasing organizations (GPOs) are contributing to the drug shortage crisis -- a concern that aligns with that of the generic drug lobby Association for Accessible Medicine (AAM). Industry experts testifying at a Finance Committee hearing Tuesday (Dec. 5) pushed the...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.